Previous studies showed reduced Aβ and improved cognition in GF or antibiotic-treated mice; however, the AD models used in those studies did not overexpress human tau (Minter et al., 2017; Minter et al., 2016; Harach et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.